Doxorubicin-induced central nervous system toxicity and protection by xanthone derivative of Garcinia Mangostana

Neuroscience

Volumn 175, Issue , 2011, Pages 292-299

  Tangpong, J ^a   Miriyala, S ^b   Noel, T ^b   Sinthupibulyakit, C ^b   Jungsuwadee, P ^b   St Clair, D K ^b  

^a School of Allied Health Sciences and Public Health   (Thailand)

^b Dept of Nutrition and Food Science   (United States)

Author keywords

Apoptosis; Doxorubicin; Neurotoxicity; Tumor necrosis factor alpha; Xanthone

Indexed keywords

3 NITROTYROSINE; 4 HYDROXYNONENAL; CARBONYL DERIVATIVE; CASPASE 3; DOXORUBICIN; PROTEIN BAX; PROTEIN BCL XL; PROTEIN P53; TUMOR NECROSIS FACTOR ALPHA; XANTHONE DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN TISSUE; BRAIN TOXICITY; CONTROLLED STUDY; DRUG ACTIVITY; ENZYME ACTIVITY; GARCINIA MANGOSTANA; MALE; MONONUCLEAR CELL; MOUSE; NEUROPROTECTION; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BRAIN CHEMISTRY; CELL LINE; DISEASE MODELS, ANIMAL; DOXORUBICIN; GARCINIA MANGOSTANA; MALE; MICE; MICE, INBRED C57BL; NERVE DEGENERATION; NEUROPROTECTIVE AGENTS; NEUROTOXINS; PLANT EXTRACTS; XANTHONES;

EID: 78951481922     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2010.11.007     Document Type: Article

References (33)

1. Ahles T.A., Saykin A.J., Furstenberg C.T., Cole B., Mott L.A., Skalla K., Whedon M.B., Bivens S., Mitchell T., Greenberg E.R., Silberfarb P.M. Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma. J Clin Oncol 2002, 20:485-493.
2. Bigotte L., Olsson Y. Retrograde transport of doxorubicin (adriamycin) in peripheral nerves of mice. Neurosci Lett 1982, 32:217-221.
3. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72:248-254.
4. Brezden C.B., Phillips K.A., Abdolell M., Bunston T., Tannock I.F. Cognitive function in breast cancer patients receiving adjuvant chemotherapy. J Clin Oncol 2000, 18:2695-2701.
5. Brookes P.S., Salinas E.P., Darley-Usmar K., Eiserich J.P., Freeman B.A., Darley-Usmar V.M., Anderson P.G. Concentration-dependent effects of nitric oxide on mitochondrial permeability transition and cytochrome c release. J Biol Chem 2000, 275:20474-20479.
6. Butterfield D.A., Lauderback C.M. Lipid peroxidation and protein oxidation in Alzheimer's disease brain: potential causes and consequences involving amyloid beta-peptide-associated free radical oxidative stress. Free Radic Biol Med 2002, 32:1050-1060.
7. Chen L.G., Yang L.L., Wang C.C. Anti-inflammatory activity of mangostins from Garcinia mangostana. Food Chem Toxicol 2008, 46:688-693.
8. De Beer E.L., Bottone A.E., Voest E.E. Doxorubicin and mechanical performance of cardiac trabeculae after acute and chronic treatment: a review. Eur J Pharmacol 2001, 415:1-11.
9. Devi Sampath P., Vijayaraghavan K. Cardioprotective effect of alpha-mangostin, a xanthone derivative from mangosteen on tissue defense system against isoproterenol-induced myocardial infarction in rats. J Biochem Mol Toxicol 2007, 21:336-339.
10. Dohare P., Garg P., Sharma U., Jagannathan N.R., Ray M. Neuroprotective efficacy and therapeutic window of curcuma oil: in rat embolic stroke model. BMC Complement Alternat Med 2008, 8:55.
11. Fox J.B., Doerr R.C., Lakritz L. Interaction between sample preparation techniques and three methods of nitrite determination. J Assoc Off Anal Chem 1982, 65:690-695.
12. Freeman J.R., Broshek D.K. Assessing cognitive dysfunction in breast cancer: what are the tools?. Clin Breast Cancer 2002, 3(Suppl 3):S91-S99.
13. Goodman J., Hochstein P. Generation of free radicals and lipid peroxidation by redox cycling of adriamycin and daunomycin. Biochem Biophys Res Commun 1977, 77:797-803.
14. Hitchcock-Bryan S., Gelber R., Cassady J.R., Sallan S.E. The impact of induction anthracycline on long-term failure-free survival in childhood acute lymphoblastic leukemia. Med Pediatr Oncol 1986, 14:211-215.
15. Jiang D.J., Hu G.Y., Jiang J.L., Xiang H.L., Deng H.W., Li Y.J. Relationship between protective effect of xanthone on endothelial cells and endogenous nitric oxide synthase inhibitors. Bioorg Med Chem 2003, 11:5171-5177.
16. Joshi G., Sultana R., Tangpong J., Cole M.P., St.Clair D.K., Vore M., Estus S., Butterfield D.A. Free radical mediated oxidative stress and toxic side effects in brain induced by the anti cancer drug adriamycin: insight into chemobrain. Free Radic Res 2005, 39:1147-1154.
17. Kolb J.P. Mechanisms involved in the pro- and anti-apoptotic role of NO in human leukemia. Leukemia 2000, 14:1685-1694.
18. Kondo M., Zhang L., Ji H., Kou Y., Ou B. Bioavailability and antioxidant effects of a xanthone-rich Mangosteen (Garcinia mangostana) product in humans. J Agric Food Chem 2009, 57:8788-8792.
19. Marquez-Valadez B., Lugo-Huitron R., Valdivia-Cerda V., Miranda-Ramirez L.R., Perez-De La Cruz V., Gonzalez-Cuahutencos O., Rivero-Cruz I., Mata R., Santamaria A., Pedraza-Chaverri J. The natural xanthone alpha-mangostin reduces oxidative damage in rat brain tissue. Nutr Neurosci 2009, 12:35-42.
20. Moongkarndi P., Kosem N., Kaslungka S., Luanratana O., Pongpan N., Neungton N. Antiproliferation, antioxidation and induction of apoptosis by Garcinia mangostana (mangosteen) on SKBR3 human breast cancer cell line. J Ethnopharmacol 2004, 90:161-166.
21. Olson R.D., Mushlin P.S. Doxorubicin cardiotoxicity: analysis of prevailing hypotheses. FASEB J 1990, 4:3076-3086.
22. Oteki T., Nagase S., Yokoyama H., Ohya H., Akatsuka T., Tada M., Ueda A., Hirayama A., Koyama A. Evaluation of adriamycin nephropathy by an in vivo electron paramagnetic resonance. Biochem Biophys Res Commun 2005, 332:326-331.
23. Pedraza-Chaverri J., Cardenas-Rodriguez N., Orozco-Ibarra M., Perez-Rojas J.M. Medicinal properties of mangosteen (Garcinia mangostana). Food Chem Toxicol 2008, 46:3227-3239.
24. Pedraza-Chaverri J., Reyes-Fermin L.M., Nolasco-Amaya E.G., Orozco-Ibarra M., Medina-Campos O.N., Gonzalez-Cuahutencos O., Rivero-Cruz I., Mata R. ROS scavenging capacity and neuroprotective effect of alpha-mangostin against 3-nitropropionic acid in cerebellar granule neurons. Exp Toxicol Pathol 2009, 61:491-501.
25. Reichenberg A., Yirmiya R., Schuld A., Kraus T., Haack M., Morag A., Pollmacher T. Cytokine-associated emotional and cognitive disturbances in humans. Arch Gen Psychiatry 2001, 58:445-452.
26. Schagen S.B., Hamburger H.L., Muller M.J., Boogerd W., van Dam F.S. Neurophysiological evaluation of late effects of adjuvant high-dose chemotherapy on cognitive function. J Neuro Oncol 2001, 51:159-165.
27. Schagen S.B., van Dam F.S., Muller M.J., Boogerd W., Lindeboom J., Bruning P.F. Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma. Cancer 1999, 85:640-650.
28. Singal P.K., Iliskovic N. Doxorubicin-induced cardiomyopathy. N Engl J Med 1998, 339:900-905.
29. Singal P.K., Li T., Kumar D., Danelisen I., Iliskovic N. Adriamycin-induced heart failure: mechanism and modulation. Mol Cell Biochem 2000, 207:77-86.
30. Tangpong J., Cole M.P., Sultana R., Estus S., Vore M., St.Clair W., Ratanachaiyavong S., St.Clair D.K., Butterfield D.A. Adriamycin-mediated nitration of manganese superoxide dismutase in the central nervous system: insight into the mechanism of chemobrain. J Neurochem 2007, 100:191-201.
31. Tangpong J., Cole M.P., Sultana R., Joshi G., Estus S., Vore M., St.Clair W., Ratanachaiyavong S., St.Clair D.K., Butterfield D.A. Adriamycin-induced, TNF-alpha-mediated central nervous system toxicity. Neurobiol Dis 2006, 23:127-139.
32. Urbain A., Marston A., Queiroz E.F., Ndjoko K., Hostettmann K. Xanthones from Gentiana campestris as new acetylcholinesterase inhibitors. Planta Med 2004, 70:1011-1014.
33. Zhang X.Y., Li W.G., Wu Y.J., Gao M.T. Amelioration of doxorubicin-induced myocardial oxidative stress and immunosuppression by grape seed proanthocyanidins in tumour-bearing mice. J Pharm Pharmacol 2005, 57:1043-1052.